Results of a local antibiotic management program on antibiotic use in a tertiary intensive care unit in hungary

Z. Peto, R. Benkó, M. Matuz, E. Csullog, A. Molnár, E. Hajdu

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: : Massive antibiotic use in intensive care units (ICU) is associated with increased microbial resistance. Therefore avoiding unneccesary antibiotic usage is essential. To achieve a more considered antibiotic prescribing practice, a new antibiotic policy was implemented at our ICU. In this paper, we evaluated the impact of this intervention, and described the aetiology and incidence of blood stream infections and selected antibiotic-resistant pathogens. Materials and Methods: : In November 2002, a local antibiotic management program (LAMP) was implemented. This included a new infectious diseases specialist consultation service and restricted authorisation to prescribe antibiotics. The effect on ward-level antibiotic use was examined by segmented regression analysis. Patient, ICU and microbiology data were also recorded and compared before and after policy implementation. Results: : The patient populations and the subsequent mortality rate were comparable before and after the implementation of the policy. Total antibiotic consumption was markedly reduced from 162.9 to 101.3 defined daily dose (DDD) per 100 patients, and per day (DDD per 100 patient-days). This was mainly accounted for a reduction in the use of quinolones, aminoglycosides, glycopeptides, metronidazol, carbepenems and third generation cephalosporins. Conclusion: : This study has confirmed that establishing a targeted LAMP, based on close co-operation between intensive care physicians and infectious disease specialists together with a restricted prescribing authority, can reduce the use of antibiotics.

Original languageEnglish
Pages (from-to)560-564
Number of pages5
JournalInfection
Volume36
Issue number6
DOIs
Publication statusPublished - Dec 2008

Fingerprint

Hungary
Tertiary Healthcare
Intensive Care Units
Anti-Bacterial Agents
Communicable Diseases
Glycopeptides
Quinolones
Aminoglycosides
Cephalosporins
Critical Care
Microbiology
Patient Care
Referral and Consultation
Regression Analysis
Physicians

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Results of a local antibiotic management program on antibiotic use in a tertiary intensive care unit in hungary. / Peto, Z.; Benkó, R.; Matuz, M.; Csullog, E.; Molnár, A.; Hajdu, E.

In: Infection, Vol. 36, No. 6, 12.2008, p. 560-564.

Research output: Contribution to journalArticle

@article{2de31d5af9ab4fca90810fc9d3d37a3a,
title = "Results of a local antibiotic management program on antibiotic use in a tertiary intensive care unit in hungary",
abstract = "Background: : Massive antibiotic use in intensive care units (ICU) is associated with increased microbial resistance. Therefore avoiding unneccesary antibiotic usage is essential. To achieve a more considered antibiotic prescribing practice, a new antibiotic policy was implemented at our ICU. In this paper, we evaluated the impact of this intervention, and described the aetiology and incidence of blood stream infections and selected antibiotic-resistant pathogens. Materials and Methods: : In November 2002, a local antibiotic management program (LAMP) was implemented. This included a new infectious diseases specialist consultation service and restricted authorisation to prescribe antibiotics. The effect on ward-level antibiotic use was examined by segmented regression analysis. Patient, ICU and microbiology data were also recorded and compared before and after policy implementation. Results: : The patient populations and the subsequent mortality rate were comparable before and after the implementation of the policy. Total antibiotic consumption was markedly reduced from 162.9 to 101.3 defined daily dose (DDD) per 100 patients, and per day (DDD per 100 patient-days). This was mainly accounted for a reduction in the use of quinolones, aminoglycosides, glycopeptides, metronidazol, carbepenems and third generation cephalosporins. Conclusion: : This study has confirmed that establishing a targeted LAMP, based on close co-operation between intensive care physicians and infectious disease specialists together with a restricted prescribing authority, can reduce the use of antibiotics.",
author = "Z. Peto and R. Benk{\'o} and M. Matuz and E. Csullog and A. Moln{\'a}r and E. Hajdu",
year = "2008",
month = "12",
doi = "10.1007/s15010-008-7377-8",
language = "English",
volume = "36",
pages = "560--564",
journal = "Infection",
issn = "0300-8126",
publisher = "Urban und Vogel",
number = "6",

}

TY - JOUR

T1 - Results of a local antibiotic management program on antibiotic use in a tertiary intensive care unit in hungary

AU - Peto, Z.

AU - Benkó, R.

AU - Matuz, M.

AU - Csullog, E.

AU - Molnár, A.

AU - Hajdu, E.

PY - 2008/12

Y1 - 2008/12

N2 - Background: : Massive antibiotic use in intensive care units (ICU) is associated with increased microbial resistance. Therefore avoiding unneccesary antibiotic usage is essential. To achieve a more considered antibiotic prescribing practice, a new antibiotic policy was implemented at our ICU. In this paper, we evaluated the impact of this intervention, and described the aetiology and incidence of blood stream infections and selected antibiotic-resistant pathogens. Materials and Methods: : In November 2002, a local antibiotic management program (LAMP) was implemented. This included a new infectious diseases specialist consultation service and restricted authorisation to prescribe antibiotics. The effect on ward-level antibiotic use was examined by segmented regression analysis. Patient, ICU and microbiology data were also recorded and compared before and after policy implementation. Results: : The patient populations and the subsequent mortality rate were comparable before and after the implementation of the policy. Total antibiotic consumption was markedly reduced from 162.9 to 101.3 defined daily dose (DDD) per 100 patients, and per day (DDD per 100 patient-days). This was mainly accounted for a reduction in the use of quinolones, aminoglycosides, glycopeptides, metronidazol, carbepenems and third generation cephalosporins. Conclusion: : This study has confirmed that establishing a targeted LAMP, based on close co-operation between intensive care physicians and infectious disease specialists together with a restricted prescribing authority, can reduce the use of antibiotics.

AB - Background: : Massive antibiotic use in intensive care units (ICU) is associated with increased microbial resistance. Therefore avoiding unneccesary antibiotic usage is essential. To achieve a more considered antibiotic prescribing practice, a new antibiotic policy was implemented at our ICU. In this paper, we evaluated the impact of this intervention, and described the aetiology and incidence of blood stream infections and selected antibiotic-resistant pathogens. Materials and Methods: : In November 2002, a local antibiotic management program (LAMP) was implemented. This included a new infectious diseases specialist consultation service and restricted authorisation to prescribe antibiotics. The effect on ward-level antibiotic use was examined by segmented regression analysis. Patient, ICU and microbiology data were also recorded and compared before and after policy implementation. Results: : The patient populations and the subsequent mortality rate were comparable before and after the implementation of the policy. Total antibiotic consumption was markedly reduced from 162.9 to 101.3 defined daily dose (DDD) per 100 patients, and per day (DDD per 100 patient-days). This was mainly accounted for a reduction in the use of quinolones, aminoglycosides, glycopeptides, metronidazol, carbepenems and third generation cephalosporins. Conclusion: : This study has confirmed that establishing a targeted LAMP, based on close co-operation between intensive care physicians and infectious disease specialists together with a restricted prescribing authority, can reduce the use of antibiotics.

UR - http://www.scopus.com/inward/record.url?scp=62249105997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62249105997&partnerID=8YFLogxK

U2 - 10.1007/s15010-008-7377-8

DO - 10.1007/s15010-008-7377-8

M3 - Article

VL - 36

SP - 560

EP - 564

JO - Infection

JF - Infection

SN - 0300-8126

IS - 6

ER -